Table 2 Genotypes and allele frequency of GLUL polymorphism rs10911021 in CAD with and without T2DM and control groups
From: GLUL rs10911021 polymorphism and risk of coronary artery disease among Egyptian individuals
rs10911021 genotype | p value | Allele frequency | ||||
|---|---|---|---|---|---|---|
CC | CT | TT | C | T | ||
CAD patients, N = 420 | 198 (47%) | 189 (45%) | 35 (8%) | < 0.001** | 585 | 255 |
CAD without T2DM, N = 180 | 90 (50%) | 81 (45%) | 9 (5%) | < 0.001** | 261 | 99 |
CAD and T2DM, N = 240 | 108 (45%) | 108 (45%) | 24 (10%) | < 0.001** | 324 | 156 |
Controls, N = 200 | 156 (78%) | 38 (19%) | 6 (3%) | 350 | 50 | |